Furthermore, in zebrafish and murine xenograft models of rhabdomyosarcoma, treatment with HDAC inhibitors recapitulates the HDAC-loss-of-function phenotype with reduced cancer stemness and self-renewal [68]. The gene discussed is HDAC9; the disease is rhabdomyosarcoma.